phrykt

TEVA Pharmaceutical Industries (TEVA) net income: $1.4B

TEVA Pharmaceutical Industries reported a net income of $1.4B for the year ended Dec 31, 2025.

From TEVA Pharmaceutical Industries's filings with the SEC · Read the filing · TEVA stock page

TEVA Pharmaceutical Industries net income by year

$417M2021−$2.4B2022−$559M2023−$1.6B2024$1.4B2025

#286 of 3,748 US companies by net income · See the full ranking

Year endedNet incomeChange
Dec 31, 2025$1.4B–
Dec 31, 2024−$1.6B–
Dec 31, 2023−$559M–
Dec 31, 2022−$2.4B–
Dec 31, 2021$417M–

Net income of similar companies

Companies in the same industry as TEVA Pharmaceutical Industries, by SEC industry code, with the closest net income. Each name opens the same page for that company.

CompanyNet income, latest yearYear ended
AbbVie$4.2BDec 31, 2025
Vertex Pharmaceuticals Inc / Ma$4BDec 31, 2025
Zoetis$2.7BDec 31, 2025
TEVA Pharmaceutical Industries$1.4BDec 31, 2025
United Therapeutics$1.3BDec 31, 2025
Royalty Pharma$771MDec 31, 2025
PTC Therapeutics$683MDec 31, 2025

Questions and answers

What is TEVA Pharmaceutical Industries's net income?

TEVA Pharmaceutical Industries reported a net income of $1.4B for the year ended Dec 31, 2025.

Numbers as reported in TEVA Pharmaceutical Industries's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology